Background: The risk of medication errors in intensive care units is high, primarily in the drug administration phase.
Local Problem: Management of high-alert medications within intensive care units in the study institution varied widely. The aim of this quality improvement project was to protocolize and centralize the management of high-alert medications in acute care settings and to implement smart intravenous infusion pump technology in intensive care units.
Objective: The increasing complexity of clinical trial protocols and the very nature of investigational drugs increase the likelihood of prescribing errors and require comprehensive control and monitoring of treatments. The aim of this study was to measure and analyze the potential risks of prescribing errors in investigational drugs.
Methods: A prospective, descriptive, and observational study was carried out in a third-level hospital in Madrid, for one month in 2017.
Objective: To carry out a Failure Mode and Effects Analysis (FMEA) to the use of oral syringes.
Methods: A multidisciplinary team was assembled within the Safety Committee. The stages of oral administration process of liquid medication were analysed, identifying the most critical and establishing the potential modes of failure that can cause errors.